TransMedics (TMDX) Gross Profit Growth (3y) (2021 - 2026)
Powered by 
Analysis
TransMedics (TMDX) Gross Profit Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 9.77% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 18.71% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 7.71% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 12.24% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.82% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 9.36% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 7.11% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 14.95% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.95% |
| 10 | TransMedics | 2.98 Bn | 2.51 Bn | 113.20 Mn | 45.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.51% |
| Mar 31, 2026 | 52.07% |
| Dec 31, 2025 | 65.24% |
| Sep 30, 2025 | 67.14% |
| Jun 30, 2025 | 88.81% |
| Mar 31, 2025 | 93.89% |
| Dec 31, 2024 | 117.63% |
| Sep 30, 2024 | 152.65% |
| Jun 30, 2024 | 131.41% |
| Mar 31, 2024 | 131.85% |
| Dec 31, 2023 | 114.91% |
| Sep 30, 2023 | 100.59% |
| Jun 30, 2023 | 167.99% |
| Mar 31, 2023 | 80.89% |
| Dec 31, 2022 | 76.88% |
| Sep 30, 2022 | 62.57% |
| Jun 30, 2022 | 62.68% |
| Mar 31, 2022 | 67.56% |
| Dec 31, 2021 | 67.04% |
| Sep 30, 2021 | 20.96% |